Cancer Drug Joins List Of Medicines In Short Supply
Los Angeles Times: Cancer Drug Doxil Joins Growing List Of Drugs In Short Supply
A crucial cancer drug has been in short supply since midsummer — and its maker, Johnson & Johnson Inc., has not been able to remedy the situation since. The medicine, Doxil, is used to treat patients with ovarian cancer, multiple myeloma or Kaposi's sarcoma after first-line treatments have failed (Adams, 11/14).